← Back to patent-cliff list
ECC-0509
Tier C — Watch / tradeECC-0509
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：AOC3
Indications (approved)：Non-alcoholic steatohepatitis, Osteoarthritis
Regional status
US
Phase II
2025-12-15
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of ECC-0509?
Approved indications include: Non-alcoholic steatohepatitis, Osteoarthritis.
When does the ECC-0509 patent expire?
No public expiry year is available for ECC-0509 yet; this page updates once verified.
How do I get a quote for ECC-0509 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29